Stockreport

UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

UCB SA UNSP/ADR  (UCBJY) 
NASDAQ:AMEX Investor Relations: ucb.com/investors
PDF 24 scientific abstracts reflect UCB's ongoing commitment to improving outcomes for people living with neurological conditions, including rare epilepsies Dravet syndrome [Read more]